Article
Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
Oncology reports - 1 Jan 2013
Maki Yuho, Soh Junichi, Ichimura Kouichi, Shien Kazuhiko, Furukawa Masashi, Muraoka Takayuki, Tanaka Norimitsu, Ueno Tsuyoshi, Yamamoto Hiromasa, Asano Hiroaki, Tsukuda Kazunori, Toyooka Shinichi, Miyoshi Shinichiro
Abstract excerpt
High expression levels of glucose transporter isoform 1 (GLUT1) and Ki-67 are reportedly associated with malignancy-related clinicopathological factors in malignant tumors. Recently, a new histological IASLC/ATS/ERS classification for lung adenocarcinoma was proposed. In this study, we investigated the clinicopathological impact of GLUT1 and Ki-67 expression on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
